Literature DB >> 6239900

Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity.

M H Claësson, R G Miller.   

Abstract

Five out of five allo-specific cytotoxic T lymphocyte (CTL) clones tested strongly suppressed the development of CTLs directed against the H-2 haplotype of the CTL clone and independent of the H-2 specificity recognized by the CTL clone. This was shown by including 100-1,000 cells from the five clones in one way mixed lymphocyte reaction (MLR) cultures in which the stimulator cells were of the same H-2 type as the CTL cells. When these cultures were assayed for cytotoxicity against the stimulator cell haplotype, the cytotoxic activity was decreased in a CTL cell dose-dependent manner by 50 to more than 90%. Suppression was usually not observed in MLR cultures where the CTL-H-2 type was identical with the responder cells or was different from both the responder or stimulator cells. Suppression was demonstrated not to be due to "cold" target inhibition at the time of cytotoxicity assay. Even if the added CTL were completely removed after 48-72 h of culture, significant suppression was obtained. Suppressive ability did not appear to be correlated with the level of allo-specific cytotoxic activity present in the CTL clones, but might involve direct killing of MLR precursor cells by cells in the added CTL clones. The suppression observed here, which is anti-self from the point of view of the added CTL clone, appears to be triggered by precursor cells in the MLR responder population recognizing MHC determinants on cells from the added CTL clone. This peculiar type of suppression, in which the regulator regulates on being recognized, has been christened the veto phenomenon and may play a role in maintenance of self tolerance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239900      PMCID: PMC2187516          DOI: 10.1084/jem.160.6.1702

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

Review 1.  Murine T lymphocyte clones with distinct immunological functions.

Authors:  A L Glasebrook; M Sarmiento; M R Loken; D P Dialynas; J Quintans; L Eisenberg; C T Lutz; D Wilde; F W Fitch
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

2.  Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells.

Authors:  M M Simon; H U Weltzien; H J Bühring; K Eichmann
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

3.  Suppression of cell-mediated lymphocytotoxicity against minor histocompatibility antigens mediated by Lyt-1+Lyt-2+ T cells of stimulator-strain origin.

Authors:  H G Rammensee; Z A Nagy; J Klein
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

4.  Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.

Authors:  P J Fink; H G Rammensee; M J Bevan
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex.

Authors:  J Klein; F Figueroa; C S David
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Activation of a Qa/Tla class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse.

Authors:  P M Brickell; D S Latchman; D Murphy; K Willison; P W Rigby
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

7.  An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it.

Authors:  R G Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

8.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

9.  Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens.

Authors:  S Muraoka; R G Miller
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

10.  Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells.

Authors:  P J Fink; I L Weissman; M J Bevan
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Separating antiviral and GVHD activities of donor T cells prior to bone marrow transplantation.

Authors:  Catherine T Jordan; John D Roback
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

3.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.

Authors:  H D Haubeck; I Minkenberg; E Kölsch
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

5.  Hematopoietic stem cell transplantation across major genetic barriers.

Authors:  Yair Reisner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  The surprising kinetics of the T cell response to live antigenic cells.

Authors:  Aaron J Tyznik; Michael J Bevan
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

7.  In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors.

Authors:  D R Martin; R G Miller
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

8.  The use of donor-derived veto cells in hematopoietic stem cell transplantation.

Authors:  Eran Ophir; Yair Reisner
Journal:  Front Immunol       Date:  2012-05-02       Impact factor: 7.561

9.  Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera.

Authors:  M G Roncarolo; H Yssel; J L Touraine; H Betuel; J E De Vries; H Spits
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.